Complete Filing Data
Aclaris Therapeutics, Inc. reported Net Income Loss of -$64.92 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Aclaris Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$64.9M | -$132.1M | -$88.5M | -$86.9M | -$90.9M | -$51.0M | -$161.4M | -$132.7M | -$68.5M | -$48.1M | -$20.6M | -$8.5M | -$5.2M |
| Cost of Revenue * | $2.1M | $2.8M | $3.4M | $4.0M | $4.7M | $5.1M | $4.1M | $4.3M | $1.2M | ||||
| Revenue * | $7.8M | $18.7M | $31.2M | $29.8M | $6.8M | $6.5M | $4.2M | $6.2M | $1.7M | ||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $513.0K | $203.0K | $791.0K | -$673.0K | -$229.0K | -$2.0K | $28.0K | $145.0K | -$121.0K | $105.0K | -$148.0K | -$9.0K | $3.0K |
| Research And Development Expense | $52.6M | $33.6M | $98.4M | $77.8M | $43.8M | $29.3M | $64.2M | $60.8M | $35.8M | $33.5M | $15.3M | $6.5M | $3.5M |
| Other Comprehensive Income Loss Net Of Tax | $513.0K | $203.0K | $791.0K | -$673.0K | -$130.0K | -$28.0K | $3.0K | $177.0K | $23.0K | -$120.0K | -$143.0K | -$9.0K | $3.0K |
| Operating Income Loss | -$76.4M | -$141.9M | -$97.4M | -$89.9M | -$89.7M | -$50.9M | -$111.1M | -$84.8M | -$54.4M | -$48.6M | -$20.7M | -$8.5M | -$5.3M |
| General And Administrative Expense | $22.0M | $22.2M | $32.4M | $25.1M | $23.6M | $20.5M | $27.8M | $25.8M | $18.9M | $11.8M | $5.3M | $2.0M | $1.8M |
| Comprehensive Income Net Of Tax | -$64.4M | -$131.9M | -$87.7M | -$87.6M | -$91.0M | -$51.0M | -$161.4M | -$132.6M | -$68.5M | -$48.2M | -$20.7M | -$8.5M | -$5.2M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Nonoperating Income Expense | $8.5M | $2.9M | -$1.1M | -$424.0K | -$2.5M | $2.7M | $2.1M | $488.0K | $104.0K | $16.0K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $99.0K | -$26.0K | -$25.0K | $32.0K | $144.0K | -$225.0K | $5.0K | ||||||
| Operating Expenses | $138.7M | $72.9M | $48.6M | $20.7M | $8.5M | $5.3M | |||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $99.0K | -$26.0K | -$25.0K | $32.0K | $144.0K | -$225.0K | $5.0K | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$68.5M | -$48.1M | -$23.1M | -$10.6M | -$7.0M | ||||||||
| Income Loss From Continuing Operations | -$86.9M | -$90.9M | -$51.2M | -$113.5M | -$82.1M | -$52.3M | |||||||
| Deferred Income Tax Liabilities Net | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$14.6M | -$15.4M | -$15.1M | -$7.6M | -$11.0M | -$16.9M | -$29.3M | -$29.6M | -$28.2M | -$20.0M | -$20.5M | -$18.8M | -$21.1M | -$18.2M | -$28.8M | -$10.7M | -$11.6M | -$15.6M | -$55.3M | -$49.9M | -$37.6M | -$38.6M | -$32.7M | -$31.2M | -$30.2M | -$22.9M | -$18.2M | -$14.8M | -$12.6M | -$11.5M | -$10.7M | -$12.9M | -$13.0M | -$4.7M | -$10.6M | -$2.6M | -$2.6M | -$2.6M | -$2.7M | -$2.2M | -$1.0M |
| Cost of Revenue * | $538.0K | $515.0K | $506.0K | $654.0K | $624.0K | $809.0K | $848.0K | $1.0M | $808.0K | $923.0K | $1.1M | $1.2M | $1.1M | $1.3M | $1.2M | $1.2M | $1.4M | $1.3M | $826.0K | $994.0K | $1.2M | $1.1M | $1.2M | $967.0K | $453.0K | ||||||||||||||||
| Revenue * | $3.3M | $1.8M | $1.5M | $4.3M | $2.8M | $2.4M | $9.3M | $1.9M | $2.5M | $19.0M | $1.5M | $1.5M | $1.7M | $1.8M | $1.8M | $1.4M | $2.0M | $1.4M | $983.0K | $886.0K | $1.3M | $3.7M | $1.1M | $3.7M | $1.1M | $999.0K | $684.0K | ||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $115.0K | $48.0K | $337.0K | $890.0K | -$99.0K | -$258.0K | -$18.0K | -$757.0K | $543.0K | -$139.0K | -$354.0K | -$748.0K | $5.0K | $25.0K | -$35.0K | -$24.0K | -$37.0K | $60.0K | -$23.0K | $30.0K | $34.0K | $65.0K | $111.0K | -$65.0K | $63.0K | -$4.0K | -$52.0K | -$12.0K | $14.0K | $142.0K | $1.0K | $3.0K | $3.0K | ||||||||
| Research And Development Expense | $13.0M | $11.4M | $11.6M | $6.0M | $8.8M | $9.8M | $23.9M | $25.3M | $22.6M | $23.7M | $18.8M | $14.3M | $14.0M | $7.9M | $7.8M | $6.2M | $6.5M | $7.7M | $16.2M | $17.5M | $19.6M | $15.2M | $14.0M | $13.6M | $10.9M | $8.0M | $7.8M | $7.2M | $9.8M | $9.5M | $9.4M | $1.8M | $1.7M | ||||||||
| Other Comprehensive Income Loss Net Of Tax | $115.0K | $48.0K | $337.0K | $890.0K | -$99.0K | -$258.0K | -$18.0K | -$757.0K | $543.0K | -$139.0K | -$354.0K | -$748.0K | $181.0K | -$44.0K | -$46.0K | -$60.0K | -$32.0K | $113.0K | -$9.0K | $57.0K | $20.0K | $72.0K | $139.0K | -$82.0K | $53.0K | $83.0K | $20.0K | -$55.0K | -$2.0K | $152.0K | $1.0K | $3.0K | $3.0K | ||||||||
| Operating Income Loss | -$17.1M | -$18.4M | -$18.1M | -$10.5M | -$12.9M | -$18.9M | -$31.6M | -$31.8M | -$29.9M | -$20.9M | -$21.0M | -$18.9M | -$20.3M | -$18.0M | -$28.5M | -$10.5M | -$11.4M | -$15.5M | -$22.9M | -$43.6M | -$27.1M | -$21.3M | -$32.0M | -$30.9M | -$18.8M | -$15.3M | -$12.9M | -$10.8M | -$13.0M | -$13.1M | -$10.6M | -$2.6M | -$2.6M | ||||||||
| General And Administrative Expense | $4.9M | $5.4M | $6.1M | $5.7M | $4.8M | $6.8M | $7.1M | $8.3M | $8.8M | $5.8M | $6.1M | $6.1M | $6.0M | $5.9M | $4.8M | $3.9M | $5.6M | $6.2M | $6.8M | $7.5M | $7.5M | $6.1M | $8.1M | $6.3M | $4.6M | $5.1M | $3.7M | $3.7M | $3.2M | $3.6M | $1.2M | $803.0K | $892.0K | ||||||||
| Comprehensive Income Net Of Tax | -$14.5M | -$15.4M | -$14.7M | -$6.7M | -$11.1M | -$17.2M | -$29.3M | -$30.3M | -$27.6M | -$20.1M | -$20.9M | -$19.5M | -$21.0M | -$18.2M | -$28.8M | -$10.7M | -$11.6M | -$15.5M | -$55.3M | -$49.8M | -$37.5M | -$32.7M | -$31.1M | -$30.3M | -$18.1M | -$14.8M | -$12.5M | -$10.7M | -$12.9M | -$12.9M | -$10.6M | -$2.6M | -$2.6M | ||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Other Nonoperating Income Expense | $1.9M | $2.0M | $2.3M | $2.2M | $1.8M | $922.0K | $462.0K | $118.0K | -$851.0K | -$155.0K | -$225.0K | -$194.0K | -$189.0K | $178.0K | -$274.0K | -$85.0K | -$230.0K | $710.0K | $760.0K | $719.0K | $564.0K | $457.0K | $371.0K | $118.0K | $118.0K | $100.0K | |||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $176.0K | -$69.0K | -$11.0K | -$36.0K | $5.0K | $53.0K | $14.0K | $27.0K | -$14.0K | $7.0K | $28.0K | -$17.0K | -$10.0K | $87.0K | $72.0K | -$43.0K | -$16.0K | $10.0K | |||||||||||||||||||||||
| Operating Expenses | $39.2M | $33.9M | $34.5M | $31.1M | $25.7M | $19.0M | $15.3M | $12.9M | $11.6M | $10.8M | $13.0M | $13.1M | $4.8M | $10.6M | $2.6M | $2.6M | $2.6M | $2.7M | $2.2M | $1.0M | |||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $176.0K | -$69.0K | -$11.0K | -$35.0K | $5.0K | $53.0K | $14.0K | $27.0K | -$14.0K | $7.0K | $29.0K | -$17.0K | $72.0K | $10.0K | |||||||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$31.2M | -$30.2M | -$22.9M | -$18.2M | -$14.8M | -$12.6M | -$11.5M | -$10.7M | -$12.9M | -$13.0M | -$4.9M | -$11.7M | -$3.3M | -$3.3M | -$3.3M | -$3.1M | -$2.7M | -$1.5M | |||||||||||||||||||||||
| Income Loss From Continuing Operations | -$21.1M | -$18.2M | -$28.8M | -$10.7M | -$11.6M | -$15.3M | -$23.1M | -$43.7M | -$27.3M | -$20.6M | |||||||||||||||||||||||||||||||
| Deferred Income Tax Liabilities Net | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $367.0K | $549.0K | $549.0K | $549.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $103.1M | $155.6M | $157.2M | $197.6M | $197.3M | $37.7M | $69.9M | $215.1M | $225.3M | $169.5M | $92.5M | -$20.8M | -$9.2M | -$2.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.0M | $24.6M | $39.9M | $45.3M | $27.3M | $22.1M | $35.9M | $57.0M | $20.2M | $30.2M | $9.9M | |||
| Cash And Cash Equivalents At Carrying Value | $20.0M | $24.6M | $39.9M | $45.3M | $27.3M | $22.1M | $34.2M | $9.9M | $10.8M | $9.6M | $19.0M | |||
| Retained Earnings Accumulated Deficit | -$967.8M | -$902.9M | -$770.8M | -$682.3M | -$595.4M | -$504.5M | -$453.5M | -$292.2M | -$159.4M | -$90.9M | -$42.8M | -$20.7M | ||
| Property Plant And Equipment Net | $761.0K | $1.0M | $1.6M | $1.1M | $1.3M | $1.7M | $2.5M | $2.3M | $2.2M | $481.0K | $360.0K | $515.0K | ||
| Other Assets Noncurrent | $2.8M | $3.1M | $4.2M | $2.7M | $3.6M | $4.5M | $4.8M | $332.0K | $279.0K | $136.0K | $22.0K | $10.0K | ||
| Liabilities Current | $28.6M | $31.6M | $31.0M | $21.9M | $22.9M | $14.9M | $22.4M | $27.3M | $12.8M | $6.2M | $1.6M | $1.5M | ||
| Liabilities And Stockholders Equity | $160.5M | $220.3M | $197.4M | $254.6M | $251.2M | $70.8M | $98.3M | $275.6M | $243.5M | $176.1M | $94.1M | $17.4M | ||
| Liabilities | $57.4M | $64.8M | $40.2M | $57.0M | $53.9M | $33.1M | $28.4M | $60.4M | $18.2M | $6.6M | $1.6M | $1.5M | ||
| Available For Sale Securities Debt Securities Current | $70.8M | $89.0M | $79.2M | $172.3M | $164.1M | $32.1M | $39.1M | $111.0M | $173.7M | $107.1M | $75.0M | $5.4M | ||
| Assets Current | $96.3M | $126.0M | $128.9M | $231.6M | $205.0M | $57.5M | $83.8M | $179.5M | $200.2M | $138.6M | $86.5M | $16.3M | ||
| Assets | $160.5M | $220.3M | $197.4M | $254.6M | $251.2M | $70.8M | $98.3M | $275.6M | $243.5M | $176.1M | $94.1M | $17.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $610.0K | $97.0K | -$106.0K | -$897.0K | -$224.0K | -$94.0K | -$66.0K | -$69.0K | -$246.0K | -$269.0K | -$149.0K | -$6.0K | ||
| Accrued Liabilities Current | $8.8M | $20.3M | $19.4M | $8.7M | $10.1M | $5.9M | $7.7M | $8.1M | $4.9M | $3.4M | $745.0K | $188.0K | ||
| Accounts Payable Current | $13.2M | $4.7M | $8.9M | $10.4M | $10.0M | $5.3M | $9.9M | $11.7M | $7.8M | $2.8M | $810.0K | $1.3M | ||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $2.3M | $2.5M | -$26.9M | $4.7M | $24.3M | $2.4M | $734.0K | $1.3M | ||||||
| Prepaid Expense And Other Assets Current | $9.5M | $13.5M | $13.0M | $2.6M | $3.1M | $4.8M | $5.9M | $1.3M | $1.7M | $204.0K | ||||
| Other Liabilities Noncurrent | $1.6M | $4.4M | $3.1M | $1.6M | $2.2M | $3.2M | $3.7M | $476.0K | $558.0K | $372.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.6M | -$15.3M | -$5.4M | $17.9M | $5.3M | -$13.9M | -$21.1M | $36.8M | -$10.0M | $20.3M | ||||
| Business Combination Contingent Consideration Liability Noncurrent | $11.0M | $8.7M | $6.2M | $33.1M | $28.4M | $4.1M | $1.7M | $934.0K | $4.4M | |||||
| Accounts Receivable Net Current | $298.0K | $484.0K | $623.0K | $772.0K | $704.0K | $563.0K | $481.0K | |||||||
| Marketable Securities Unrealized Gain Loss | $513.0K | $203.0K | $791.0K | -$673.0K | -$229.0K | $376.0K | $28.0K | |||||||
| Available For Sale Securities Debt Securities Noncurrent | $60.6M | $90.3M | $62.8M | $12.2M | $34.2M | $15.0M | $36.9M | $7.2M | $518.0K | |||||
| Intangible Assets Net Excluding Goodwill | $269.0K | $7.0M | $7.0M | $7.1M | $7.2M | $7.3M | $7.3M | |||||||
| Other Liabilities Current | $2.8M | $2.7M | $2.6M | $603.0K | $637.0K | $142.0K | ||||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | $2.2M | $2.2M | $2.2M | $3.1M | $4.2M | $7.4M | ||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $120.1M | $131.7M | $144.1M | $130.2M | $133.8M | $142.0M | $156.3M | $179.8M | $176.8M | $219.8M | $235.8M | $180.2M | $216.6M | $233.8M | $112.3M | $40.8M | $49.4M | $58.1M | $85.3M | $137.2M | $182.3M | $146.3M | $174.2M | $200.5M | $244.3M | $168.1M | $160.3M | $81.1M | $90.2M | $83.2M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $25.3M | $25.4M | $30.4M | $47.7M | $22.8M | $35.8M | $39.0M | $31.2M | $44.7M | $61.7M | $68.3M | $36.3M | $53.6M | $113.4M | $35.3M | $25.4M | $32.6M | $54.0M | $29.9M | $31.7M | $34.2M | $26.6M | $46.0M | $54.9M | $60.1M | $32.7M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $25.3M | $25.4M | $30.4M | $47.7M | $22.8M | $35.8M | $39.0M | $31.2M | $44.7M | $61.7M | $68.3M | $36.3M | $53.6M | $113.4M | $35.3M | $23.6M | $54.9M | $20.2M | $60.1M | $32.7M | $23.7M | $30.2M | $17.8M | $31.8M | $13.1M | $25.4M | $9.9M | $8.5M | |||||||||
| Retained Earnings Accumulated Deficit | -$948.0M | -$933.4M | -$917.9M | -$806.3M | -$798.7M | -$787.7M | -$769.3M | -$740.0M | -$710.5M | -$654.7M | -$634.7M | -$614.2M | -$572.6M | -$551.5M | -$533.3M | -$491.4M | -$480.7M | -$469.1M | -$434.9M | -$379.6M | -$329.7M | -$253.6M | -$220.9M | -$189.7M | -$136.5M | -$118.3M | -$103.5M | -$79.4M | -$68.7M | -$55.9M | |||||||
| Property Plant And Equipment Net | $811.0K | $868.0K | $942.0K | $1.1M | $1.3M | $1.5M | $1.8M | $1.9M | $1.5M | $1.1M | $1.3M | $1.3M | $1.2M | $1.3M | $1.4M | $1.9M | $2.2M | $2.2M | $2.9M | $4.2M | $4.0M | $4.4M | $4.4M | $2.2M | $1.2M | $938.0K | $706.0K | $461.0K | $434.0K | $417.0K | |||||||
| Other Assets Noncurrent | $2.8M | $3.0M | $3.2M | $3.2M | $3.4M | $4.0M | $2.7M | $2.9M | $3.3M | $2.9M | $3.1M | $3.4M | $3.7M | $3.9M | $4.0M | $4.8M | $4.7M | $4.7M | $5.0M | $5.3M | $2.4M | $452.0K | $457.0K | $341.0K | $195.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | |||||||
| Liabilities Current | $25.6M | $26.8M | $21.5M | $18.8M | $15.7M | $20.1M | $27.3M | $22.8M | $18.3M | $19.8M | $16.2M | $16.7M | $17.8M | $14.9M | $14.5M | $12.8M | $17.7M | $20.6M | $39.0M | $42.7M | $36.2M | $22.3M | $20.1M | $13.8M | $10.0M | $8.4M | $5.6M | $4.6M | $5.5M | $3.7M | |||||||
| Liabilities And Stockholders Equity | $175.5M | $189.1M | $198.1M | $182.4M | $161.1M | $174.1M | $218.4M | $235.6M | $229.7M | $267.6M | $278.0M | $226.5M | $263.5M | $288.0M | $161.4M | $71.9M | $85.0M | $96.8M | $160.4M | $217.2M | $253.2M | $176.2M | $201.8M | $220.6M | $261.4M | $176.8M | $166.2M | $86.1M | $96.1M | $87.3M | |||||||
| Liabilities | $55.4M | $57.4M | $54.0M | $52.2M | $27.2M | $32.1M | $62.0M | $55.9M | $52.9M | $47.8M | $42.2M | $46.3M | $46.9M | $54.2M | $49.1M | $31.1M | $35.6M | $38.6M | $75.1M | $80.0M | $70.9M | $29.8M | $27.6M | $20.2M | $17.1M | $8.7M | $5.9M | $4.9M | $5.9M | $4.1M | |||||||
| Available For Sale Securities Debt Securities Current | $70.7M | $74.4M | $75.0M | $80.1M | $88.3M | $92.3M | $64.0M | $88.6M | $126.1M | $186.4M | $180.3M | $143.3M | $144.3M | $118.2M | $93.0M | $29.8M | $35.5M | $25.0M | $61.5M | $83.9M | $102.6M | $107.7M | $118.6M | $132.1M | $167.8M | $137.8M | $129.7M | $66.2M | $62.2M | $72.1M | |||||||
| Assets Current | $100.6M | $104.2M | $108.8M | $132.3M | $117.6M | $135.3M | $123.1M | $132.9M | $184.4M | $256.6M | $259.4M | $190.9M | $205.8M | $241.3M | $134.5M | $58.0M | $71.0M | $82.7M | $145.4M | $137.9M | $156.8M | $145.5M | $171.2M | $192.3M | $234.1M | $175.8M | $157.3M | $85.6M | $95.6M | $86.8M | |||||||
| Assets | $175.5M | $189.1M | $198.1M | $182.4M | $161.1M | $174.1M | $218.4M | $235.6M | $229.7M | $267.6M | $278.0M | $226.5M | $263.5M | $288.0M | $161.4M | $71.9M | $85.0M | $96.8M | $160.4M | $217.2M | $253.2M | $176.2M | $201.8M | $220.6M | $261.4M | $176.8M | $166.2M | $86.1M | $96.1M | $87.3M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $597.0K | $482.0K | $434.0K | $427.0K | -$463.0K | -$364.0K | -$1.1M | -$1.1M | -$354.0K | -$1.5M | -$1.3M | -$972.0K | -$3.0K | -$184.0K | -$140.0K | -$44.0K | $15.0K | $47.0K | -$1.0K | $8.0K | -$49.0K | -$116.0K | -$188.0K | -$328.0K | -$113.0K | -$166.0K | -$249.0K | -$54.0K | $1.0K | $3.0K | |||||||
| Accrued Liabilities Current | $9.8M | $11.4M | $8.6M | $4.7M | $5.8M | $6.6M | $15.2M | $8.7M | $7.3M | $9.2M | $7.6M | $5.7M | $7.4M | $6.9M | $3.6M | $3.8M | $9.3M | $10.4M | $6.1M | $27.6M | $20.8M | $8.5M | $7.6M | $5.7M | $3.5M | $2.5M | $2.0M | $2.8M | $2.2M | $921.0K | |||||||
| Accounts Payable Current | $9.2M | $8.8M | $6.4M | $7.7M | $7.3M | $10.8M | $9.6M | $11.4M | $8.2M | $7.7M | $5.7M | $8.1M | $7.6M | $4.2M | $7.3M | $5.1M | $5.5M | $6.9M | $17.8M | $14.2M | $14.6M | $13.7M | $12.5M | $8.2M | $6.5M | $5.8M | $3.6M | $1.8M | $3.3M | $2.8M | |||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $100.0K | $1.5M | $300.0K | $800.0K | $200.0K | $2.8M | $1.7M | -$1.5M | -$800.0K | $2.2M | -$3.4M | -$1.2M | $900.0K | $4.8M | $16.4M | $626.0K | $1.8M | $866.0K | |||||||||||||||||||
| Prepaid Expense And Other Assets Current | $4.2M | $3.2M | $12.0M | $4.3M | $6.2M | $6.8M | $19.7M | $12.7M | $12.9M | $7.9M | $10.1M | $10.6M | $7.1M | $8.6M | $5.4M | $1.9M | $2.1M | $2.8M | $2.1M | $2.8M | $3.4M | $9.2M | $3.4M | $4.8M | $5.6M | $5.3M | $3.9M | $1.5M | $1.6M | $1.6M | |||||||
| Other Liabilities Noncurrent | $1.7M | $1.9M | $4.3M | $2.2M | $2.4M | $3.0M | $1.8M | $1.9M | $2.0M | $1.6M | $1.8M | $2.0M | $2.5M | $2.9M | $3.0M | $3.1M | $3.3M | $3.5M | $4.0M | $5.1M | $3.3M | $1.8M | $1.8M | $534.0K | $375.0K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.8M | -$4.0M | -$555.0K | $9.0M | $13.2M | $18.1M | -$22.8M | $34.7M | |||||||||||||||||||||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | $10.6M | $10.5M | $9.0M | $10.0M | $9.2M | $9.0M | $32.5M | $30.8M | $32.3M | $26.0M | $23.8M | $27.2M | $26.2M | $25.3M | $20.5M | $4.1M | $3.4M | $3.4M | $1.7M | $1.7M | $934.0K | $5.2M | $5.2M | $5.2M | $4.4M | ||||||||||||
| Accounts Receivable Net Current | $194.0K | $250.0K | $318.0K | $343.0K | $325.0K | $373.0K | $346.0K | $431.0K | $686.0K | $597.0K | $637.0K | $633.0K | $811.0K | $939.0K | $817.0K | $887.0K | $775.0K | $933.0K | $673.0K | $19.4M | $15.8M | $1.0M | $2.2M | $529.0K | $658.0K | ||||||||||||
| Marketable Securities Unrealized Gain Loss | $115.0K | $48.0K | $337.0K | $890.0K | -$99.0K | -$258.0K | -$18.0K | -$757.0K | $543.0K | -$139.0K | -$354.0K | -$748.0K | $5.0K | $25.0K | -$35.0K | ||||||||||||||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $71.3M | $81.1M | $85.2M | $45.7M | $38.8M | $33.2M | $83.9M | $91.0M | $33.6M | $7.2M | $24.0M | $45.7M | $34.5M | $14.4M | $8.0M | ||||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $6.9M | $6.9M | $7.0M | $7.0M | $7.0M | $7.0M | $7.1M | $7.1M | $7.1M | $7.1M | $7.2M | $7.2M | $7.2M | $69.8M | $71.5M | $7.3M | $7.3M | $7.3M | $7.4M | ||||||||||||||||||
| Other Liabilities Current | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $2.7M | $716.0K | $693.0K | $669.0K | $647.0K | $625.0K | $591.0K | $610.0K | $624.0K | $642.0K | $991.0K | $868.0K | ||||||||||||||||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $3.1M | $3.0M | $3.3M | $2.3M | $2.7M | $14.5M | ||||||||||||||||||||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$5.9M | $74.5M | $26.7M | $72.9M | $225.1M | $18.4M | -$30.3M | $128.3M | $100.4M | $116.8M | $96.4M | $10.6M | |
| Investing Cash Flow * | $48.4M | -$69.8M | $46.2M | $12.6M | -$167.6M | $6.4M | $105.7M | $9.4M | -$55.7M | -$61.9M | -$77.0M | -$1.8M | -$4.5M |
| Operating Cash Flow * | -$47.1M | -$20.1M | -$78.3M | -$67.6M | -$52.1M | -$38.6M | -$96.4M | -$100.8M | -$54.7M | -$34.6M | -$20.4M | -$7.6M | -$4.9M |
| Increase Decrease In Accounts Payable | $8.4M | -$4.2M | -$1.5M | $368.0K | $3.7M | -$5.2M | -$3.2M | $7.0M | $4.6M | $1.8M | -$359.0K | $819.0K | $303.0K |
| Share Based Compensation | $12.4M | $10.9M | $20.5M | $15.0M | $14.1M | $11.2M | $16.2M | $20.1M | $14.4M | $6.1M | $891.0K | $27.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $89.0M | $86.1M | $183.2M | $178.0M | $67.8M | $54.6M | $210.5M | $239.4M | $152.5M | $87.1M | $6.1M | $3.7M | |
| Payments To Acquire Property Plant And Equipment | $111.0K | $121.0K | $1.3M | $605.0K | $308.0K | $453.0K | $1.6M | $1.4M | $1.2M | $232.0K | $507.0K | $417.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.9M | $1.3M | $2.3M | $5.6M | -$1.7M | -$3.2M | -$62.0K | $4.3M | $8.0K | $1.3M | $152.0K | -$7.0K | |
| Payments To Acquire Marketable Securities | $39.7M | $120.0M | $135.7M | $164.8M | $235.2M | $47.7M | $137.4M | $161.6M | $197.3M | $148.8M | $82.5M | $5.0M | $4.5M |
| Increase Decrease In Accrued Liabilities | $12.0M | $592.0K | $470.0K | -$3.7M | -$2.0M | $6.8M | $607.0K | $2.5M | $552.0K | $175.0K | -$8.0K | ||
| Depreciation Depletion And Amortization | $454.0K | $807.0K | $863.0K | $797.0K | $923.0K | $1.3M | $6.4M | $1.9M | $402.0K | $120.0K | $90.0K | ||
| Proceeds From Stock Options Exercised | $32.0K | $94.0K | $157.0K | $1.5M | $70.0K | $207.0K | $577.0K | $235.0K | $121.0K | ||||
| Increase Decrease In Accounts Receivable | $20.0K | -$186.0K | -$139.0K | -$149.0K | -$4.9M | $809.0K | $4.4M | ||||||
| Stock Issued During Period Value Share Based Compensation | -$377.0K | -$8.0K | -$1.6M | -$669.0K | -$38.0K | -$52.0K | -$62.0K | $4.0K | |||||
| Payments Related To Tax Withholding For Share Based Compensation | $446.0K | $409.0K | $102.0K | $34.0K | $3.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$275.0K | -$55.0K | $30.0K | $100.8M | $10.9M | -$120.0K | $358.0K | $209.0K | -$231.0K | ||||||||
| Investing Cash Flow * | $19.1M | $16.8M | $25.8M | $29.9M | -$75.3M | $13.9M | $8.6M | $56.2M | $6.0M | $10.2M | $745.0K | ||||||
| Operating Cash Flow * | -$13.1M | -$20.8M | -$26.4M | -$21.0M | -$12.2M | -$6.8M | -$31.3M | -$21.9M | -$12.7M | -$6.9M | -$2.8M | ||||||
| Increase Decrease In Accounts Payable | $1.7M | $1.9M | -$2.2M | -$1.9M | $1.8M | -$4.3M | -$197.0K | $316.0K | $831.0K | $2.0M | $385.0K | ||||||
| Share Based Compensation | $3.5M | $2.1M | $6.8M | $2.3M | $2.7M | $3.5M | $4.9M | $5.1M | $3.2M | $1.2M | $43.0K | ||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $30.0M | $17.0M | $54.9M | $44.7M | $10.5M | $22.9M | $82.0M | $92.1M | $23.3M | $10.2M | $822.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $43.0K | $135.0K | $553.0K | $164.0K | $124.0K | $284.0K | $298.0K | $195.0K | $40.0K | $77.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$8.2M | -$2.0M | $874.0K | -$188.0K | $2.3M | -$338.0K | -$1.8M | -$1.0M | $2.6M | -$71.0K | $626.0K | ||||||
| Payments To Acquire Marketable Securities | $10.0M | $28.5M | $14.6M | $85.8M | $8.9M | $73.1M | $35.6M | $17.2M | |||||||||
| Increase Decrease In Accrued Liabilities | -$12.9M | -$1.2M | -$1.8M | -$2.4M | $2.2M | $8.5M | $788.0K | -$1.5M | $39.0K | $16.0K | |||||||
| Depreciation Depletion And Amortization | $128.0K | $243.0K | $198.0K | $208.0K | $288.0K | $576.0K | $2.2M | $222.0K | $50.0K | ||||||||
| Proceeds From Stock Options Exercised | $37.0K | $416.0K | $25.0K | $394.0K | $209.0K | ||||||||||||
| Increase Decrease In Accounts Receivable | -$68.0K | $75.0K | $202.0K | $10.0K | $45.0K | -$4.7M | $11.0M | ||||||||||
| Stock Issued During Period Value Share Based Compensation | -$95.0K | -$463.0K | -$121.0K | $53.0K | -$18.0K | -$188.0K | $86.0K | -$440.0K | $378.0K | ||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $275.0K | $55.0K | $7.0K | $3.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.53 | -$1.71 | -$1.27 | -$1.33 | -$1.60 | -$1.20 | -$3.90 | -$4.03 | -$2.44 | -$2.25 | -$3.79 | -$6.15 | -$6.45 |
| Common Stock Shares Authorized | 400.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 77.0M | |
| Common Stock Shares Outstanding | 120.5M | 107.9M | 70.9M | 66.7M | 61.2M | 45.1M | 41.5M | 41.2M | 30.9M | 26.1M | 20.2M | 2.7M | |
| Common Stock Shares Issued | 120.5M | 107.9M | 70.9M | 66.7M | 61.2M | 45.1M | 41.5M | 41.2M | 30.9M | 26.1M | 20.2M | 2.7M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 42.5M | 41.3M | 32.9M | 28.1M | 21.4M | 6.1M | 1.7M | 1.1M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 122.6M | 77.3M | 69.8M | 65.2M | 56.7M | 42.5M | 41.3M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 122.6M | 77.3M | 69.8M | 65.2M | 56.7M | 42.5M | 41.3M | ||||||
| Earnings Per Share Basic | $-0.53 | $-1.71 | $-1.27 | $-1.33 | $-1.60 | $-1.20 | $-3.90 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.13 | -$0.12 | -$0.11 | -$0.15 | -$0.24 | -$0.41 | -$0.42 | -$0.42 | -$0.30 | -$0.31 | -$0.31 | -$0.35 | -$0.34 | -$0.57 | -$0.25 | -$0.28 | -$0.37 | -$1.34 | -$1.21 | -$0.91 | -$0.99 | -$1.06 | -$1.01 | -$0.98 | -$0.74 | -$0.63 | -$0.56 | -$0.48 | -$0.49 | -$0.50 | -$0.62 | -$0.65 | -$0.28 | -$5.12 | -$1.52 | -$1.61 | -$1.76 | -$1.75 | -$1.61 | -$0.95 |
| Common Stock Shares Authorized | 400.0M | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||||||||
| Common Stock Shares Outstanding | 108.3M | 108.3M | 108.3M | 71.4M | 71.3M | 71.2M | 70.8M | 70.8M | 67.2M | 66.7M | 66.7M | 61.7M | 61.2M | 61.2M | 52.1M | 42.9M | 42.7M | 41.8M | 41.4M | 41.3M | 41.3M | 31.0M | 31.0M | 30.9M | 30.8M | 26.7M | 26.1M | 21.4M | 21.4M | 20.3M | |||||||||||
| Common Stock Shares Issued | 108.3M | 108.3M | 108.3M | 71.4M | 71.3M | 71.2M | 70.8M | 70.8M | 67.2M | 66.7M | 66.7M | 61.7M | 61.2M | 61.2M | 52.1M | 42.9M | 42.7M | 41.8M | 41.4M | 41.3M | 41.3M | 31.0M | 31.0M | 30.9M | 30.8M | 26.7M | 26.1M | 21.4M | 21.4M | 20.3M | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 61.2M | 54.0M | 50.3M | 42.8M | 42.1M | 41.6M | 41.4M | 41.3M | 41.2M | 31.0M | 30.9M | 30.9M | 28.8M | 26.6M | 26.1M | 21.4M | 20.7M | 20.2M | 2.3M | 2.2M | 2.0M | ||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 122.6M | 122.6M | 122.4M | 71.4M | 71.3M | 71.1M | 70.8M | 70.6M | 66.9M | 66.7M | 66.0M | 61.4M | 61.2M | 54.0M | 50.3M | ||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 122.6M | 122.6M | 122.4M | 71.4M | 71.3M | 71.1M | 70.8M | 70.6M | 66.9M | 66.7M | 66.0M | 61.4M | 61.2M | 54.0M | 50.3M | ||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.12 | $-0.13 | $-0.12 | $-0.11 | $-0.15 | $-0.24 | $-0.41 | $-0.42 | $-0.42 | $-0.30 | $-0.31 | $-0.31 | $-0.35 | $-0.34 | $-0.57 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.4M | $10.9M | $20.5M | $15.0M | $14.1M | $11.2M | $16.2M | $20.1M | $14.4M | $6.1M | $891.0K | $27.0K |
| Costs And Expenses | $84.2M | $160.7M | $128.6M | $119.6M | $96.5M | $57.4M | $115.3M | $90.9M | $56.0M | |||
| Additional Paid In Capital | $1.07B | $1.06B | $928.1M | $880.8M | $793.0M | $542.3M | $523.5M | $507.4M | $384.9M | $260.7M | $135.5M | |
| Capital Expenditures Incurred But Not Yet Paid | $21.0K | $24.0K | $143.0K | $124.0K | $161.0K | $274.0K | $11.0K | $2.0K | $91.0K | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $8.0K | -$163.0K | $1.6M | -$669.0K | $78.3M | |||||||
| Licensing Expenses | $5.2M | $12.7M | $14.7M | $7.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $3.1M | $3.5M | $3.0M | $2.9M | $2.1M | $5.9M | $6.5M | $6.8M | $4.2M | $3.7M | $2.3M | $3.7M | $3.8M | $2.7M | $1.9M | $3.3M | $3.5M | $3.3M | $4.8M | $4.9M | $4.7M | $5.2M | $5.1M | $3.2M | $1.2M | ||||
| Costs And Expenses | $20.4M | $20.2M | $19.5M | $14.8M | $15.6M | $21.3M | $40.9M | $33.7M | $32.4M | $39.9M | $22.5M | $20.4M | $22.0M | $19.8M | $30.3M | $11.9M | $13.4M | $16.9M | $23.8M | $55.7M | $28.3M | $22.5M | $35.7M | $32.1M | ||||||
| Additional Paid In Capital | $1.07B | $1.06B | $1.06B | $936.0M | $933.0M | $930.1M | $926.8M | $920.9M | $887.6M | $876.0M | $871.8M | $795.4M | $789.2M | $785.5M | $645.7M | $532.2M | $530.1M | $527.2M | $520.2M | $516.8M | $512.0M | $400.1M | $395.3M | $390.5M | $380.9M | $286.6M | $264.0M | $160.6M | $159.0M | $139.1M |
| Capital Expenditures Incurred But Not Yet Paid | $41.0K | $111.0K | $16.0K | $24.0K | $210.0K | $91.0K | $40.0K | |||||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $21.0K | -$10.0K | -$55.0K | -$86.0K | $30.0K | -$11.0K | $88.0K | $49.0K | $29.0K | $1.0M | -$2.6M | |||||||||||||||||||
| Licensing Expenses | $1.9M | $1.3M | $1.0M | $1.8M | $1.3M | $1.0M | $7.3M | $550.0K | $1.1M | $7.3M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.